ACGN — Aceragen Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual balance sheet for Aceragen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	71.4	42.8	37.7	32.5	12
Net Total Accounts Receivable
Net Total Receivables	—	—	—	—	4.21
Prepaid Expenses
Total Current Assets	72.8	46.3	41.4	34	17.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.207	1.15	0.974	0.756	0.544
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	73	47.5	42.4	34.9	101
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	9.02	54.5	7.03	4.86	21.4
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	9.03	58.7	134	5.41	62.2
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	64	-11.2	-91.2	29.5	38.9
Total Liabilities & Shareholders' Equity	73	47.5	42.4	34.9	101
Total Common Shares Outstanding
Total Preferred Shares Outstanding